Please be aware that this event has been cancelled.
Effectively Utilizing Multi-Omics from Early Discovery to Reverse Translation
The Inaugural Multi-Omics Based Drug Discovery & Development Summit is your uniquely comprehensive scientific forum. We focus on unlocking the full potential of genomics, epigenomics, transcriptomics, proteomics, and metabolomics across drug development and discovery pipelines.
At this event, you'll learn gold-standard omics methodologies and master data harmonization and integration. You can also discover how to apply multi-omics for target identification and precision medicine. Don't miss your opportunity to optimize multi-omics data analysis and generate unique biomedical insights, directly informing therapeutic pipelines.
Key Case Studies From...
Multimodal Network Approach for Discovery of Novel Targets in Rheumatoid Arthritis
Advance Multi-Omics Data Management with Secure Architecture & Visualization Capabilities
Effectively with Challenging Samples to Achieve Unique, Holistic Multi-Omics Insights into Health & Disease
Define the Human Phenome by Effectively & Strategically Integrating Layers of Omics Data
Apply Complex Omics Analysis of Individual Patient Data to Guide Development of Efficacious, Tolerable Precision Therapies
Benefits of Attending
Achieve
data integration across genomics, epigenomics, transcriptomics, proteomics, metabolomics, and beyond to facilitate comprehensive analysis and generate a holistic picture of health, with data from Poseida Therapeutics & Phenome Health
Navigating
emerging omics technologies, data storage platforms, and machine learning capabilities to develop a robust omics workflow and expand the scope of multi-omics analysis, with learnings from UC San Diego & Resilient Biotics
Unlocking
novel insights with efficient translation of large-scale omics data into actionable biomedical conclusions to innovate novel treatment options for patients, with lessons from Boehringer Ingelheim & Gilead Sciences
Illuminating
disease mechanisms, signalling pathways and patient response with multi-omics analysis to better inform therapeutic development and patient selection, with data-driven case studies from Boehringer Ingelheim & Arda Therapeutics
Unleashing
the potential of multi-omics across drug development pipelines, from target identification and precision medicine to reverse translation to revolutionize R&D and clinical studies, with learnings from Multiomic Health & Sinopia Biosciences
Hear From Your Peers
‘I value participating in this meeting because it provides a unique platform to discuss strategic integration of multi-omic approaches for enabling the discovery and development of life-changing medicines’
Senior Scientist
‘This Summit is a valuable opportunity to exchange practical insights on spatial omics workflows, discover emerging best practices, and build collaborations that advance both core operations and translational research. It is a chance to both contribute and learn in a fast-evolving field’
Director, Single-Cell & Spatial Omics Core
